Vascular Calcification in Chronic Kidney Disease: Pathogenesis and Clinical Implications

Journal of Renal Nutrition

Volumn 19, Issue 1, 2009, Pages 78-81

  Shioi, Atsushi ^a   Nishizawa, Yoshiki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; BONE; CALCINOSIS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; DISEASE COURSE; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; METABOLISM; MORTALITY; PATHOLOGY;

APOPTOSIS; BONE AND BONES; CALCINOSIS; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; HUMANS; HYPERCALCEMIA; HYPERPHOSPHATEMIA; KIDNEY FAILURE, CHRONIC;

EID: 58049178414     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2008.10.015     Document Type: Article

References (14)

1. Menon V., Gul A., and Sarnak M.J. Cardiovascular risk factors in chronic kidney disease. Kidney Int 68 (2005) 1413-1418
2. London G.M. Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function. J Am Soc Nephrol 14 (2003) S305-s309
3. Covic A., Gusbeth-Tatomir P., and Goldsmith D.J. Arterial stiffness in renal patients: an update. Am J Kidney Dis 45 (2005) 965-977
4. Schwarz U., Buzello M., Ritz E., et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant 15 (2000) 218-223
5. Haydar A.A., Hujairi N.M., Covic A.A., et al. Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: a study comparing EBCT-generated coronary artery calcium scores and coronary angiography. Nephrol Dial Transplant.19 (2004) 2307-2312
6. Nitta K., Akiba T., Suzuki K., et al. Assessment of coronary artery calcification in hemodialysis patients using multi-detector spiral CT scan. Hypertens Res 27 (2004) 527-533
7. Raggi P., Boulay A., Chasan-Taber S., et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?. J Am Coll Cardiol 39 (2002) 695-701
8. Block G.A., and Port F.K. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis 35 (2000) 1226-1237
9. Shioi A. Vascular calcification. In: Morii H., Nishizawa Y., and Massry S. (Eds). Calcium in internal medicine (2002), Springer, London 479-494
10. Son B.K., Kozaki K., Iijima K., et al. Gas6/Axl-PI3K/Akt pathway plays a central role in the effect of statins on inorganic phosphate-induced calcification of vascular smooth muscle cells. Eur J Pharmacol 556 (2007) 1-8
11. Jono S., Shioi A., Ikari Y., et al. Vascular calcification in chronic kidney disease. J Bone Miner Metab 24 (2006) 176-181
12. Lomashvili K.A., Garg P., Narisawa S., et al. Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification. Kidney Int 73 (2008) 1024-1030
13. Bucay N., Sarosi I., Dunstan C.R., et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12 (1998) 1260-1268
14. Morony S., Tintut Y., Zhang Z., et al. Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice. Circulation 117 (2008) 411-420